Greater Improvements Seen for Most Secondary Efficacy Measures with FP vs Placebo

= statistically significantly different than placebo

• = P=0.05, FP vs. Placebo

— = Pɬ.05, FP vs. Placebo

FLTA3025 SFCA3007 FLTA3025 SFCA3006

Measure FP250 FP250 FP500 FP500

TDI (dyspnea) — — ?

CRDQ (QOL) ? ? —

CBSQ (cough/sputum) — — —

PEF ? ? ? ?

NT awakenings ? ? ? ?

Ventolin use ? — ? ?

Time to COPD exac. — — — —

*

*

*

*

Previous slide

Next slide

Back to first slide

View graphic version